BRBCX
Price
$14.54
Change
+$0.02 (+0.14%)
Updated
Jul 3 closing price
Net Assets
3.17B
JDJCX
Price
$8.48
Change
+$0.06 (+0.71%)
Updated
Jul 3 closing price
Net Assets
1.33B
Interact to see
Advertisement

BRBCX vs JDJCX

Header iconBRBCX vs JDJCX Comparison
Open Charts BRBCX vs JDJCXBanner chart's image
BlackRock Tactical Opportunities Inv C
Price$14.54
Change+$0.02 (+0.14%)
VolumeN/A
Net Assets3.17B
JHancock Diversified Macro C
Price$8.48
Change+$0.06 (+0.71%)
VolumeN/A
Net Assets1.33B
BRBCX vs JDJCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BRBCX vs. JDJCX commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRBCX is a Buy and JDJCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BRBCX has more cash in the bank: 3.17B vs. JDJCX (1.33B). BRBCX (0.00) and JDJCX (0.00) have matching dividends . BRBCX was incepted earlier than JDJCX: BRBCX (32 years) vs JDJCX (6 years). JDJCX (2.37) is less costly to investors than BRBCX (1.80). BRBCX is a more actively managed with annual turnover of: 146.00 vs. JDJCX (0.00). BRBCX (1000) and JDJCX (1000) have matching initial minimum investment requirements. BRBCX annual gain was more profitable for investors over the last year : 7.07 vs. JDJCX (-14.43). BRBCX return over 5 years is better than : 22.01 vs. JDJCX (7.83).
BRBCXJDJCXBRBCX / JDJCX
Total Expense Ratio1.802.3676%
Annual Report Gross Expense Ratio1.802.3776%
Fund Existence32 years6 years-
Gain YTD3.931-5.039-78%
Front LoadN/AN/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets3.17B1.33B238%
Annual Yield % from dividends0.000.00-
Returns for 1 year7.07-14.43-49%
Returns for 3 years22.99-9.69-237%
Returns for 5 years22.017.83281%
Returns for 10 years24.07N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AILLX27.750.29
+1.06%
Aristotle Core Equity I-2
FRSLX26.830.22
+0.83%
Nuveen Small/Mid Cap Growth Opp A
NSBCX64.830.44
+0.68%
Nuveen Dividend Growth C
FAPLX12.930.07
+0.54%
Fidelity Advisor Healthy Future M
IUEFX28.52-0.02
-0.07%
JPMorgan International Focus R5